Eurofins-Cerep SA
PAR:ALECR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Eurofins-Cerep SA
Total Current Assets
Eurofins-Cerep SA
Total Current Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Eurofins-Cerep SA
PAR:ALECR
|
Total Current Assets
€72.7m
|
CAGR 3-Years
15%
|
CAGR 5-Years
18%
|
CAGR 10-Years
15%
|
|
|
Sartorius Stedim Biotech SA
PAR:DIM
|
Total Current Assets
€1.4B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
11%
|
CAGR 10-Years
15%
|
|
Eurofins-Cerep SA
Glance View
Eurofins-Cerep SA engages in providing preclinical drug research services. The company is headquartered in Celle-Levescault, Nouvelle-Aquitaine and currently employs 211 full-time employees. The company went IPO on 2010-03-19. The Company, using its BioPrint technology systems that analyzes pharmaceutical drugs on the market, those that have been withdrawn, and those that failed in the development stages, builds up predictive models of the potential of new drugs. These predictions are based on the drugs' chemical structure and their performance in vitro. The firm then offers solutions to the pharmaceutical and biotechnology sectors on reducing time and costs in the early stages of the drug development process. Clients can also gain access to some of the Company's technology by subscribing to BioPrint. In December 2013, it sold Cerep Inc, its American subsidiary, to Eurofins-Panlabs Inc, part of the Eurofins Scientific SE group.
See Also
What is Eurofins-Cerep SA's Total Current Assets?
Total Current Assets
72.7m
EUR
Based on the financial report for Dec 31, 2024, Eurofins-Cerep SA's Total Current Assets amounts to 72.7m EUR.
What is Eurofins-Cerep SA's Total Current Assets growth rate?
Total Current Assets CAGR 10Y
15%
Over the last year, the Total Current Assets growth was 9%. The average annual Total Current Assets growth rates for Eurofins-Cerep SA have been 15% over the past three years , 18% over the past five years , and 15% over the past ten years .
